# The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation

> **NCT06864052** · NA · NOT_YET_RECRUITING · sponsor: **Ewha Womans University Seoul Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Stroke
- Atrial Fibrillation

## Interventions

- **DRUG:** Administration of Apixaban
- **DRUG:** Administration of Edoxaban

## Key facts

- **NCT ID:** NCT06864052
- **Lead sponsor:** Ewha Womans University Seoul Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2029-09-30
- **Final completion:** 2029-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06864052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06864052, "The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06864052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*